The dynamics of reactive oxygen species in photodynamic therapy with tetra sulfophenyl-porphyrin

Acta Physiologica Hungarica

Volumn 97, Issue 1, 2010, Pages 41-51

  Clichici, Simona ^a   Filip, A ^a   Daicoviciu, D ^a   Ion, R M ^b   Mocan, T ^a   Tatomir, C ^c   Rogojan, L ^d   Olteanu, D ^a   Muresan, A ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CHEMISTRY AND PETROCHEMISTRY ICECHIM   (Romania)

^c Departments of Radiobiology and Tumor Biology   (Romania)

^d Emergency District Hospital   (Romania)

Author keywords

MMPs; Photodynamic therapy; Reactive oxygen species; TSPP; Tumor

Indexed keywords

5,10,15,20 TETRASULFOPHENYLPORPHYRIN; GELATINASE A; MALONALDEHYDE; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TISSUE LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; RAT; TUMOR NECROSIS; WALKER CARCINOMA;

ANIMALS; ANTIOXIDANTS; CARCINOMA 256, WALKER; KINETICS; MALE; MATRIX METALLOPROTEINASE 2; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 77949550933     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.97.2010.1.5     Document Type: Article

References (42)

1. Alexandrova R, Ion RM, Stoykova E, Sheemlinkov S: In vitro investigation on cytotoxic activity of TS4PP (5,10,15,20-tetra(4-sulfophenyl) porphyrin. Proc. of SPIE. 5226, 423-427 (2003)
2. Alexandrova R, Sabotinov O, Stoykova EV, Ion RM, Shurulnikov S, Minchev G: In vitro cytotoxicity assessment of [5, 10, 15, 20-tetra(4-sulfophenyl)- porphyrin] on tumor and nontumor cell lines. Proc. of SPIE. 5449, 227-234 (2004)
3. Bradford, MM: A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-254 (1976)
4. Calin MA, Ion RM, Herascu N: Kramers-Kronig analysis of 5, 10, 15, 20-tetra sulfophenyl-porphyrin. J. Optoelecton. Adv. Mater. 7(6), 3155-3160 (2005)
5. Constantin C, Neagu M, Manda G, Ion RM, Iordachescu DI: The effect of laser activation on 5, 10, 15, 20 - tetra sulphophenyl-porphyrin loaded in K 562 cells and human normal mononiclear cells. Roum. Arch. Microbiol. Immunol. 63(3-4), 159-168 (2004)
6. Conti M, Moran PC, Levillain P: Improved fluorimetric determination of malondialdehyde. Clin. Chem. 37, 1273-1275 (1991)
7. Dougherty TJ, Gomer CJ, Henderson BW, et al: Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905 (1998)
8. Ferrario A, Chantrain C, Von Tiehl K, Buckley S, Rucker N, Shalinsky D, Shimada H, DeClerck YA, Gomer J: The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res. 64, 2328-2332 (2004)
9. Filip A, Clichici S, Muresan A, Daicoviciu D, Tatomir C, Login C, Dreve S, Gherman C: Effects of photodynamic therapy with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma. Exp.Oncol. 30(3), 1-8 (2008)
10. Girotti AW, Kriska T: Role of lipid hydroperoxides in photo-oxidative stress signaling. Antioxid. Redox Signal. 6(2), 301-310 (2004)
11. Girotti AW: Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J. Photochem. Photobiol. B. 63 (1-3), 103-113 (2001)
12. Gomer CJ, Ferrario A, Luna M, Rucker N, Wong S: Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 38(5), 516-521 (2006)
13. Granelli-Piperno A, Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148, 223-234 (1978)
14. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate copolymerized substrates. Anal. Biochem. 102(1), 196-202 (1980)
15. Hu ML: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 233, 380-384 (1994)
16. Ion RM: Spectral studies of TSPP and TSNP used in PDT. Monomer-dimer equilibrium. Rom. J. Biophys. 6(3-4), 213-218 (1996)
17. Ion RM: The spectral study of the porphyrins used in PDT. The aggregation processes. St. Cerc. Biotehnol. 29-30, 205-212 (1997)
18. Ion RM, Planner A, Wiktorowicz K, Frackowiak D: Incorporation of various porphyrins into blood cells measured via flow-cytometry, absorption and emission spectroscopy. Acta Biochim. Pol. 45(3), 833-845 (1998)
19. Ion RM, Grigorescu M, Scarlat FS, Niculescu AV, Gunnaydin K: Light, electron and photon irradiation of 5, 10, 15, 20-tetra (4-sulfophenyl) porphyrin used in cancer therapy. J. BUON. 5, 201-207 (2000)
20. Ion RM, Brezoi DV: New nano-sized sensing drug and its clinical application. Solid State Phenomena. 106, 79-82 (2005)
21. Ion RM: Photodynamic therapy (PDT): a photochemical concept with medical applications. Rev. Roum. Chim. 52(12), 1093-1102 (2007)
22. Iosif A, Grummt UW: Aggregation of tetrakis (4-methylpyridyl)porphyrin and tetrakis(4-sulphonatophenyl) porphyrin in water. J. Prakt. Chem. 339, 420-425 (1997)
23. Janazsewska A, Bartosz G: Assay of antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand. J. Lab. Invest. 62, 231-236 (2002)
24. Jiraskova M, Jirasek L, Stork J, Vosmik F, Jirsa M: Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases. Cas. Lek. Cesk. 142 (8), 493-499 (2003)
25. Joshi PG, Joshi K, Joshi NB: Effect of hematoporphyrin derivate and light on sulfhydryl groups in brain tumour cells. Indian J. Exp. Biol. 33(10), 721-724 (1995)
26. Kemnitz K, Sakaguchi T: Water-soluble porphyrin monomer-dimmer systems: fluorescence dynamics and thermodynamic properties. Chem. Phys. Lett. 196, 497-503 (1992)
27. Kim MM, Kim SK: Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett. 15 (580), 2661-2666 (2006)
28. Kolarova H, Bajgar R, Tomankova K, Nevrelova P, Mosinger J: Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro. Toxicol. In Vitro 21 (7), 1287-1291 (2007)
29. Komagoe K, Tamagake K, Katsu T: The influence of aggregation of porphyrins on the efficiency of photogeneration of hydrogen peroxide in aqueous solution. Chem. Pharm. Bull. 54(7), 1004-1009 (2006)
30. Magi B, Ettorre A, Liberatori S, Bini L, Andreassi M, Frosali S, Neri P, Pallini V, Di Stefano A: Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death. Differ. 11(8), 842-852 (2004)
31. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, et al: Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol. 146(4), 552-567 (2002)
32. Pazos MDC, Nader HB: Effect of photodynamic therapy on the extracellular matrix and associated components. Braz. J. Med. Biol. Res. 40(8), 1025-1035 (2007)
33. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233, 357-363 (1994)
34. Saczko J, Kulbacka J, Chwilkowska A, Lugowski M, Banas T: Levels of lipid peroxidation in A549 cells after PDT in vitro. Rocz. Akad. Med. Bialymst. 49(Suppl 1), 82-84 (2004)
35. Schmidt-Erfurth U, Miller JW, Sickenberg M: Photodynamic therapy with Verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a Phases 1 and 2 study. Arch. Ophthalmol. 117, 1177-1178 (1999)
36. Smith GJ, Ghiggino KP, Bennett LE, Nero TL: The "Q-band" absorption spectra of hematoporphyrin monomer and aggregate in aqueous solution. Photochem. Photobiol. 49, 49-52 (1989)
37. Srivastava M, Ahmad N, Gupta S, Mukhtar H: Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. J. Biol. Chem. 276(18), 15481-15488 (2001)
38. Stoykova E, Nedkova K, Sabotonov O, Ion RM, Alexandrova R: In vitro cytotoxicity assessment of second generation photosensitizers for photodynamic therapy. J. Optoelectron. Adv. Mater. 9(2), 490-493 (2007)
39. Stoykova E, Sabotinov E, Ion RM, Alexandrova R: Reliability of the survival dose estimated from in vitro cytotoxicity testing in photodynamic therapy. Biotechnology & Biotechnological Equipment, 22(2), 754-758 (2008)
40. Tatar O, Adam A, Shinoda K, Eckert T, Schariot GB et al: Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br. J. Ophthalmol. 91, 1183-1189 (2007)
41. Tsaytler PA, CO'Flaherty M, Sakharov DV, Krijgsveld J, Egmond MR: Immediate protein targets of photodynamic treatment in carcinoma cells. J. Proteome Res. 7 (9), 3868-3878 (2008)
42. Winkelman J: The distribution of tetraphenylporfinesulfonate in the tumor-bearing rat. Cancer Res. 22, 589-596 (1962)